OCDX 17.63 (+0.46%)
GB00BMDNH979Medical Diagnostics & ResearchDiagnostics & Research

Ortho Clinical Diagnostics Holdings (OCDX) Competitor Comparison

We are evaluating the key criteria listed to compare Ortho Clinical Diagnostics Holdings (OCDX) against its competitors in the Diagnostics & Research industry.

Linearity 5 years - OCDX ranking 3 / 58

These are the competitors of Ortho Clinical Diagnostics Holdings in the industry Diagnostics & Research ranked by linearity 5 years
1. Co-Diagnostics CODX
100.26
2. Qiagen QGEN
64.85
3. Ortho Clinical Diagnostics Holdings OCDX
33.4
4. DarioHealth DRIO
31.71
5. Icon ICLR
30.55
6. IQVIA Holdings IQV
29.27
7. Fulgent Genetics FLGT
28.3
8. Syneos Health SYNH
24.79
9. CareDx CDNA
17.75
10. Heska HSKA
15.42
11. DexCom DXCM
15.4
12. Pacific Biosciences of California PACB
13.96
13. Twist Bioscience TWST
13.6
14. Charles River Laboratories CRL
11.82
15. Anixa Biosciences ANIX
11.07
16. Agilent Technologies A
10.29
17. Inotiv NOTV
9.71
18. Thermo Fisher Scientific TMO
8.92
19. Olink Holding OLK
8.53
20. Danaher DHR
8.18
21. Precipio PRPO
8.1
22. Myriad Genetics MYGN
7.15
23. Mettler-Toledo MTD
6.94
24. IDEXX Laboratories IDXX
6.59
25. Exact Sciences EXAS
6.06
26. Aspira Womens Health AWH
5.9
27. Guardant Health GH
5.32
28. PerkinElmer PKI
4.97
29. Trinity Biotech TRIB
4.91
30. Personalis PSNL
4.67
31. Waters WAT
3.83
32. Psychemedics PMD
3.7
33. Enzo Biochem ENZ
3.59
34. Laboratory Corp of America Holdings LH
3.49
35. Sotera Health SHC
3.44
36. NeoGenomics NEO
3.39
37. Illumina ILMN
3.11
38. Quest Diagnostics DGX
3.02
39. Neogen NEOG
2.92
40. National Research NRC
2.84
41. Bioventus BVS
2.76
42. Interpace Biosciences IDXG
2.45
43. Exagen XGN
2.44
44. Sera Prognostics SERA
2.37
45. Neuronetics STIM
2.28
46. Global Cord Blood CO
2.23
47. MDxHealth MDXH
1.91
48. Biodesix BDSX
1.8
49. MaxCyte MXCT
1.79
50. Prenetics Global PRE
1.7
51. bioAffinity Technologies BIAF
1.67
52. Organovo Holdings ONVO
1.6
53. SeqLL SQL
1.38
54. Medpace Holdings MEDP
1.15
55. Meridian Bioscience VIVO
0.99
56. Natera NTRA
0.67
57. RadNet RDNT
0.62
58. Lantheus Holdings LNTH
0.3

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.

If you accept cookies, we use them to improve and personalize your experience. Manage Cookies